Cargando…
Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control
In spite of advances in tuberculosis (TB) chemotherapy, TB is still airborne deadly disorder as a major issue of health concern worldwide today. Extensive researches have been focused to develop nov-el drug delivery systems to shorten the lengthy therapy approaches, prevention of relapses, reducing...
Autores principales: | Hussain, Afzal, Singh, Sima, Das, Sabya Sachi, Anjireddy, Keshireddy, Karpagam, Subramanian, Shakeel, Faiyaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637229/ https://www.ncbi.nlm.nih.gov/pubmed/30714523 http://dx.doi.org/10.2174/1567201816666190201144815 |
Ejemplares similares
-
Editorial: Nanomedicine-Based Drug Delivery Systems: Recent Developments and Future Prospects
por: Shakeel, Faiyaz
Publicado: (2023) -
Recent insights on nanomedicine for augmented infection control
por: Singh, Sima, et al.
Publicado: (2019) -
Elastic liposomes as novel carriers: recent advances in drug delivery
por: Hussain, Afzal, et al.
Publicado: (2017) -
Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis
por: Das, Sabya Sachi, et al.
Publicado: (2020) -
Development of tetracycline-modified nanoparticles for bone-targeted delivery of anti-tubercular drug
por: Liang, Qiuzhen, et al.
Publicado: (2023)